Privacy and security teams should respond with a clear inventory of AI use cases, a jurisdictional review of data processing, and documented decisions on what is permitted. They should coordinate legal, security, and procurement so controls are consistent across teams. If regulators question a platform, the organisation needs evidence of due diligence, policy enforcement, and ongoing monitoring.
What regulators are really testing when they scrutinise public GenAI use
Regulatory scrutiny of public GenAI platforms is usually not only about whether a tool is innovative. It is about whether the organisation can explain its data flows, justify the lawful basis for processing, and show that the platform was approved through a controlled decision process. Public GenAI also tends to blur the boundary between experimentation and production use, which makes documentation, ownership, and policy enforcement much more important. The EU General Data Protection Regulation (GDPR) is a useful reference point here because it forces teams to think about purpose limitation, transparency, and accountability rather than treating AI adoption as a purely technical choice.
Security teams often focus on prompt abuse, but regulators usually ask a wider question: who approved the use case, what data can enter the platform, where the data may go, and how the organisation would prove those decisions after the fact. In practice, many teams discover their real weakness only after a policy exception has already become normal operating behaviour.
How privacy, legal, and security controls should work together
The right response is to treat public GenAI platforms as a governed service rather than an individual productivity tool. Privacy should define what categories of data are prohibited, restricted, or acceptable under specific conditions. Security should translate that policy into control points such as access restrictions, logging, acceptable-use guardrails, and monitoring for unmanaged adoption. Legal and procurement should confirm contractual terms, cross-border processing implications, retention language, and any disclosure obligations tied to the platform’s operating model.
A practical workflow usually starts with a use-case inventory. That inventory should distinguish between internal experimentation, customer-facing use, and any workflow that could expose personal, confidential, or regulated data. From there, the organisation needs a jurisdictional review that asks where prompts, outputs, telemetry, and support data are processed or retained. If the platform is approved, the approval should be specific to the use case and data class, not a blanket endorsement of the vendor.
- Define which data types are allowed, and which are prohibited, before broad use begins.
- Record the business purpose, owner, and review date for each approved use case.
- Confirm whether the platform stores prompts or output and whether administrators can access them.
- Align policy, training, and monitoring so staff cannot follow conflicting instructions.
For broader governance of AI risk, teams can also use the NIST AI 600-1 GenAI Profile as a control-oriented reference, especially where the question is how to operationalise review, oversight, and risk treatment. The guidance breaks down when teams approve tools informally, fail to distinguish protected from non-protected data, or assume that vendor defaults are sufficient to satisfy internal governance.
Where public GenAI scrutiny gets messy in real organisations
Tighter control over public GenAI platforms often slows adoption, so organisations must balance user convenience against legal and privacy exposure. That tradeoff becomes harder when employees use the same platform for harmless drafting one day and sensitive analysis the next. The issue is not just the tool itself, but the absence of a consistent rule for when content becomes regulated, confidential, or reportable.
One common edge case is the difference between public chat interfaces and enterprise-managed GenAI services. They may look similar to users, but their data handling, retention, and administrative visibility can be materially different. Another is the use of public GenAI for vendor evaluation, policy drafting, or code assistance, where the content may not be obviously sensitive but still reveals internal strategy or security posture. Guidance also varies by jurisdiction, and there is not yet full consensus on how far existing privacy obligations extend to all forms of generated content, which means teams should document their interpretation rather than assuming one standard answer.
If the organisation cannot prove that its review process covered data classification, legal basis, and monitoring, then the platform should be treated as ungoverned until that evidence exists.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST AI RMF, NIST CSF 2.0 and CIS Controls v8 set the technical controls, while EU AI Act and NIS2 define the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| EU AI Act | GOV-02 — Risk Management | Regulators scrutinise AI use cases, approvals, and accountability. |
| Recommendation — Document permitted GenAI uses and keep review evidence current. | ||
| NIST AI RMF | GOV-1 — Map, Measure, and Manage AI Risks | The question is about governing public GenAI under regulatory scrutiny. |
| Recommendation — Map each GenAI use case to its risks and recorded controls. | ||
| NIST CSF 2.0 | GV.RM-01 — Risk Management Strategy | Teams need coordinated governance, evidence, and ongoing monitoring. |
| Recommendation — Align privacy and security decisions under one risk management process. | ||
| CIS Controls v8 | 6.1 — Establish and Maintain a Data Management Process | Public GenAI scrutiny often turns on data classification and handling. |
| Recommendation — Classify data before allowing it into public GenAI platforms. | ||
| NIS2 | Art. 21 — Risk-management measures | Jurisdictional scrutiny can implicate governance and operational risk controls. |
| Recommendation — Record governance measures and keep them demonstrable to regulators. | ||
Practitioner Guidance
What to prioritise: Establish a single approval path for public GenAI use so privacy, security, and procurement are not making separate decisions about the same platform. The highest-value early work is usually a use-case register paired with a data-use matrix, because that exposes where policy is vague, inconsistent, or unenforceable.
What to verify: Check whether approved use cases are tied to named owners, specific data classes, and a review date. Also verify that staff understand the difference between permitted experimentation and permitted operational use, because that boundary is where most regulatory explanations become weak.
Common mistake: Treating a vendor approval as if it were a use-case approval. A platform may be acceptable for low-risk drafting but not for customer data, regulated records, or internal confidential material, and regulators will usually care about that distinction.
Practitioner takeaway: The defensible posture is not “we use GenAI carefully,” but “we can prove exactly which uses are allowed, which data is excluded, and who is accountable when that boundary is crossed.”
Related resources from NHI Mgmt Group
- What do security teams get wrong about privacy and security controls in data platforms?
- How should security teams evaluate DSPM platforms that also need to prevent exposure in SaaS and GenAI workflows?
- How should security teams evaluate cloud security platforms for Australian public sector use?
- How should security teams protect GenAI projects at public events and demos?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 9, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
